$6.2 Million Wellcome Award for Non-Addictive Painkiller Research
Researchers in Nashville, Tennessee, and Glasgow, Scotland, received a Wellcome Trust Discover Award for research into a non-addictive painkiller.
Will Journavx, a New, Non-Addictive Painkiller, Eliminate Opioid Addiction?
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.
Elephant Tranquilizer, the Most Powerful Opioid Ever, Is Causing Overdose Deaths
The CDC issues an alert on carfentanil, a synthetic opioid considered to be 100 times more powerful than fentanyl.
Senior Citizens and Substance Use Disorders
The Wall Street Journal calls attention to the unique problems of aging addicts in America.
Tranq Is a Non-Opiate Sedative That Maims and Kills
A recent symposium on the xylazine crisis focuses on the sedative known as tranq and its disturbing side effects.
Breakthrough Study on GLP-1 Agonist Drugs Used to Treat Addiction
A research report from the Oracle Center for Real-World Data and the Parkinson School of Health Sciences shows the impact of GLP-1 agonist drugs on addiction.